1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDoD Prostate Cancer, Idea Development Award (HT942525PCRPIDA) is sponsored by Dept. of the Army -- USAMRAA. This grant supports idea development for prostate cancer research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DoD Prostate Cancer, Idea Development Award | HT942525PCRPIDA DoD Prostate Cancer, Idea Development Award | HT942525PCRPIDA Science and Technology and other Research and Development Dept.
of the Army -- USAMRAA Opportunity Information: Apply for HT942525PCRPIDA The FY25 DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) is a discretionary federal research grant run by the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA).
It is designed to fund prostate cancer research projects built around genuinely new ideas, especially concepts that take an innovative or unconventional approach and could meaningfully advance the PCRP mission.
A central requirement is that every application must directly address at least one of the program's FY25 PCRP Overarching Challenges, meaning proposals need to be clearly tied to the specific high-priority problem areas the PCRP has identified for that fiscal year rather than being general prostate cancer research.
This opportunity is open to applicants without stated restrictions in the listing ("Eligible Applicants: Unrestricted"), and it is categorized as a grant supporting science, technology, and other research and development activities under CFDA 12. 420. The funding opportunity number is HT942525PCRPIDA, and it was created on May 20, 2025.
The application closing date is August 29, 2025. The posting anticipates making about 17 awards, but the award ceiling is not specified in the provided source details, so prospective applicants would need to consult the full announcement for budget caps, project period limits, and cost rules. One distinctive feature of the FY25 IDA is a dedicated New Investigator Category.
While established investigators are eligible, the program specifically encourages submissions from researchers who are still in the early part of their careers, defined here as being within 10 years of completing their terminal degree. To strengthen feasibility and ensure appropriate domain expertise, new investigators are required to include one or more collaborators who have demonstrated experience in prostate cancer research.
In practical terms, this category is intended to bring fresh perspectives into the field while still anchoring projects in proven prostate cancer knowledge through collaboration.
Overall, this award is aimed at idea-driven, high-impact prostate cancer research that aligns tightly with the FY25 PCRP priority challenges, with an explicit pathway for newer investigators to compete by pairing innovative concepts with experienced prostate cancer collaborators. The Dept.
of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled " DoD Prostate Cancer, Idea Development Award " and is now available to receive applicants. Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12. 420 .
This funding opportunity was created on 2025-05-20. Applicants must submit their applications by 2025-08-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
The number of recipients for this funding is limited to 17 candidate(s). Eligible applicants include: Unrestricted. Apply for HT942525PCRPIDA [Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: Your browser does not support the video tag.
FY25 DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) FAQs What is the FY25 DoD PCRP Idea Development Award (IDA)? The FY25 DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) is a discretionary federal research grant run by the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA).
It is intended to fund prostate cancer research projects that are built around genuinely new ideas, particularly those that are innovative or unconventional and could meaningfully advance the PCRP mission. What types of research does this award support? This award supports prostate cancer research projects that are idea-driven and high-impact.
A key emphasis is on new concepts and approaches, including innovative or unconventional strategies that have the potential to advance the goals of the PCRP. Is there a specific focus applicants must address? Yes.
Every application must directly address at least one of the FY25 PCRP Overarching Challenges. Proposals need to be clearly tied to those identified high-priority problem areas for FY25 rather than being general prostate cancer research. Can I submit a general prostate cancer research proposal?
Based on the requirements provided, proposals should not be framed as general prostate cancer research. Applications must directly address at least one FY25 PCRP Overarching Challenge. Who is running and administering this funding opportunity?
The program is run by the Department of the Army and is administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). Is this a grant or a contract? It is a grant opportunity (a discretionary federal research grant).
What is the funding opportunity number? The funding opportunity number is HT942525PCRPIDA. What is the CFDA number and program category?
The listing categorizes this as a grant supporting science, technology, and other research and development activities under CFDA 12. 420. Who is eligible to apply?
The listing states "Eligible Applicants: Unrestricted," meaning there are no stated eligibility restrictions in the information provided. Are new investigators encouraged to apply? Yes.
The FY25 IDA includes a dedicated New Investigator Category and specifically encourages submissions from researchers in the early part of their careers. How does the program define a "new investigator" for this opportunity? A new investigator is defined here as being within 10 years of completing their terminal degree.
Are new investigators required to have collaborators? Yes. New investigators must include one or more collaborators who have demonstrated experience in prostate cancer research.
Why does the New Investigator Category require experienced collaborators? The stated purpose is to strengthen feasibility and ensure appropriate domain expertise, bringing fresh perspectives while anchoring projects in proven prostate cancer knowledge through collaboration. Are established investigators allowed to apply?
Yes. Established investigators are eligible, even though the program includes a dedicated pathway encouraging new investigators. When was this opportunity created?
The funding opportunity was created on May 20, 2025. What is the application deadline? The application closing date is August 29, 2025.
How many awards does the program expect to make? The posting anticipates making about 17 awards. What is the maximum award amount (award ceiling)?
The award ceiling is not specified in the provided details. Applicants would need to consult the full announcement for any budget caps. Are project period limits, budget caps, and cost rules provided here?
No. The provided information notes that prospective applicants should consult the full announcement for budget caps, project period limits, and cost rules. What is the main goal of the Idea Development Award? The main goal is to fund genuinely new, potentially high-impact prostate cancer research ideas that align tightly with the FY25 PCRP priority challenges.
What makes this award "distinctive" compared to a standard research grant? Based on the information provided, distinctive elements include the strong emphasis on genuinely new ideas (including innovative or unconventional approaches), the requirement to directly address at least one FY25 PCRP Overarching Challenge, and the dedicated New Investigator Category with a collaboration requirement.
Browse more opportunities from the same agency: Dept. of the Army -- USAMRAA Browse more opportunities from the same category: Science and Technology and other Research and Development Next opportunity: AK-25-01, Alaska Coastal Marine Institute Administrative Award Previous opportunity: Poison Control Program Competitive Supplement Are you interested in learning about about how to apply for this government funding opportunity?
You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT942525PCRPIDA Applicants also applied for: Applicants who have applied for this opportunity (HT942525PCRPIDA) also looked into and applied for these: Verticals-enabling Intelligent Network Systems Apply for 25 539 Agency: U.S. National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $6,000,000 FY 2025 Competitive Academic Agreement Program (CAAP) Apply for 693JK325NF0003 Funding Number: 693JK325NF0003 Agency: Pipeline and Hazardous Materials Safety Admin Category: Science and Technology and other Research and Development Funding Amount: $1,000,000 DOD Peer Reviewed Cancer, Career Development Award – Scholar Option Apply for HT942525PRCRPCDASO Funding Number: HT942525PRCRPCDASO Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option Apply for HT942525PRCRPCDAFRO Funding Number: HT942525PRCRPCDAFRO Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DOD Peer Reviewed Cancer, Idea Award Apply for HT942525PRCRPIA Funding Number: HT942525PRCRPIA Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DOD Peer Reviewed Cancer, Clinical Trial Award Apply for HT942525PRCRPCTA Funding Number: HT942525PRCRPCTA Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DOD Peer Reviewed Cancer, Impact Award Apply for HT942525PRCRPIPA Funding Number: HT942525PRCRPIPA Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent Staff Research Program Apply for W911NF25S0007 Funding Number: W911NF25S0007 Agency: Dept of the Army -- Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 DoD Toxic Exposures Investigator-Initiated Research Award Apply for HT942525TERPIIRA Funding Number: HT942525TERPIIRA Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DoD Toxic Exposures Translational Research Partnership Award Apply for HT942525TERPTRPA Funding Number: HT942525TERPTRPA Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DoD Toxic Exposures Clinical Trial Partnership Award Apply for HT942525TERPCTPA Funding Number: HT942525TERPCTPA Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent Monitoring support for Wood Stork Reproduction in Lake Okeechobee and Overlapping Core Foraging Areas (CFAs) for U.S. Army Corps of Engineers, Jacksonville District Apply for W9126G252SOI4435 Funding Number: W9126G252SOI4435 Agency: Fort Worth District Category: Science and Technology and other Research and Development DoD Breast Cancer, Breakthrough Award Levels 1 and 2 Apply for HT942525BCRPBTA122 Funding Number: HT942525BCRPBTA122 Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent DoD Breast Cancer, Clinical Research Extension Award Apply for HT942525BCRPCREA2 Funding Number: HT942525BCRPCREA2 Agency: Dept.
of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent Oyster Larval Transport/Hydrodynamic Modeling for the Herring Bay Sanctuary, Maryland Apply for W81EWF 25 SOI 0008 Funding Number: W81EWF 25 SOI 0008 Agency: Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Number: N0001425SF004 Category: Science and Technology and other Research and Development Natural Resources and Endangered Species Research and Support at Fort Cavazos, Texas Apply for W81EWF 25 SOI 0009 Funding Number: W81EWF 25 SOI 0009 Agency: Engineer Research and Development Center Category: Science and Technology and other Research and Development Cooperative Agreement for affiliated Partner with the Gulf Coast Cooperative Ecosystem Studies Unit (CESU) Apply for G25AS00321 Funding Number: G25AS00321 Agency: Geological Survey Category: Science and Technology and other Research and Development Young Innovators STEM Lab: Empowering Future Partners to the USA Apply for OFOP0002102 Funding Number: OFOP0002102 Agency: U.S. Mission to India Category: Science and Technology and other Research and Development Connecting Moroccan Youth with U.S. Space Science and Technology Apply for OFOP0002098 Funding Number: OFOP0002098 Agency: U.S. Mission to Morocco Category: Science and Technology and other Research and Development Grant application guides and resources It is always free to apply for government grants.
However the process may be very complex depending on the funding opportunity you are applying for. Let us help you! Inside Our Applicants Portal Applicant Video Guides - The grant application process can be challenging to follow.
We can help you with intuitive video guides to speed up the process and eliminate errors in submissions. Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience. Request more information: Would you like to learn more about this funding opportunity, similar opportunities to " HT942525PCRPIDA ", eligibility, application service, and/or application tips? Submit an inquiry below: Request for More Information
According to the current listing, eligibility includes: Not specified in search results, but generally open to organizations involved in medical research. Confirm the full requirements in the official notice before applying.
DoD Prostate Cancer, Idea Development Award (HT942525PCRPIDA) is funded by Dept. of the Army -- USAMRAA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.Distinctive Features: The FY26 CTRA offers two funding levels:• Funding Level 1 to support smaller, less complex preclinical and/or clinical research.• Funding Level 2 to support larger, more complex preclinical and/or clinical research.The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories:• Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission.• Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field.Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed. Funding Opportunity Number: HT942526DMDRPCTRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $8.5M total program funding.
DoW Duchenne Muscular Dystrophy, Idea Development Award is sponsored by Dept. of the Army -- USAMRAA. Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation.
After SBIR reauthorization, the U.S. Army released five new small-business topics under Army FUZE — Ka-Band metamaterial radar, a Li-ion 6T battery open topic, in-transit-visibility blockchain, modular UAS payloads, and the xTech|Phantum prize competition. Awards run from $150K to $300K per Phase I. But the bigger story is the Army's shift from funding parts to funding whole systems. Here is what each topic funds and how to compete.
Read articleDARPA transferred its first autonomous-ready H-60Mx Black Hawk to the Army on March 20, capping a decade of ALIAS research. Now the same technology underpins an SBIR XL opportunity for small businesses building wildfire autonomy.
Read article